HomeOwner SearchCategory Search
Visit USCODrug Metabolism and Disposition [Published: 2020-07-22. Issue: vol. 48, no. 8, August 2020]
Serial Registration
Copyright Title
Drug Metabolism and Disposition [Published: 2020-07-22. Issue: vol. 48, no. 8, August 2020]
Status
Published
on 22 Jul 2020
Year of Creation
2020
Copyright Claimant
American Society for Pharmacology and Experimental Therapeutics
Registration Number
TX0008887431
on 22 Jul 2020Copyright Summary
The U.S. Copyright record (Registration Number: TX0008887431) dated 22 Jul 2020, pertains to an electronic file (eService) titled "Drug Metabolism and Disposition [Published: 2020-07-22. Issue: vol. 48, no. 8, August 2020]" created in 2020. The copyright holder is American Society for Pharmacology and Experimental Therapeutics, known for their creative contributions in serial registration. For any inquiries concerning this copyrighted material, kindly reach out to American Society for Pharmacology and Experimental Therapeutics.
Application Details
Registration Number
TX0008887431
Registration Date
7/22/2020
Year of Creation
2020
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
American Society for Pharmacology and Experimental Therapeutics
Physical Description
Electronic file (eService)
First Publication Nation
United States
ISSN
1521-009X
Notes
Rights Note: Richard C. Dodenhoff, American Society for Pharmacology and Experimental Therapeutics, 1801 Rockville Pike, Suite 201, Rockville, MD, 20852-1633, United States, (301) 634-7997, rdodenhoff@aspet.org
Copyright Local Holdings: vol. 48, no. 8, August 2020 Created 2020 Pub. 2020-07-22 Reg. 2020-07-22 TX0008887431 SMARTIN
Statements
Application Title Statement: Drug Metabolism and Disposition
Author Statement: American Society for Pharmacology and Experimental Therapeutics employer for hire Domicile: United States Authorship: Collective Work Authorship and Component Work(s) authored or fully owned by the Collective Work Author
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.